Dietary phyto-oestrogens and bone health
- 1 November 2003
- journal article
- review article
- Published by Cambridge University Press (CUP) in Proceedings Of The Nutrition Society
- Vol. 62 (4), 877-887
- https://doi.org/10.1079/pns2003309
Abstract
The use of dietary phyto-oestrogens as a possible option for the prevention of osteoporosis has raised considerable interest because of the increased concern about the risks associated with the use of hormone-replacement therapy. However, the evidence in support of a bone-sparing effect in post-menopausal women is still not sufficiently convincing. Most studies have been performed on soyabean isoflavones (genistein and daidzein), either in the purified form or as a soyabean-based product or extract. In vitro studies using primary cell cultures or stabilised cell lines indicate that treatment with genistein may lead to a reduction in bone resorption, but effects on bone formation have also been shown. Investigations using animal models have provided convincing evidence of major improvements in bone mass or bone turnover following soyabean feeding. Cross-sectional observations in South-East Asian populations with moderately high intakes of soyabean isoflavones (50 mg/d) have shown that women in the high quartile of intake have higher bone mineral density (BMD) and reduced bone turnover, an effect that has not been shown in populations with low average intakes. Human trials have given an indication of a possible effect on lumbar spine BMD, although they have been either short term (<6 months) or methodologically weak. Unresolved issues are: the optimal dose compatible with safety; the individual differences in response that can be related to diet and genotypes; the duration of exposure. Furthermore, there needs to be an evaluation of the relative biological effects of phyto-oestrogens other than isoflavones (lignans, resorcylic acid lactones, flavanols, coumestans) that are also present in European diets.Keywords
This publication has 64 references indexed in Scilit:
- Isoflavone intake in four different European countries: the VENUS approachBritish Journal of Nutrition, 2003
- Investigating the role of natural phyto-oestrogens on bone health in postmenopausal womenBritish Journal of Nutrition, 2003
- Guidelines for usingin vitromethods to study the effects of phyto-oestrogens on boneBritish Journal of Nutrition, 2003
- Relationship between Estrogen Receptor-Binding and Estrogenic Activities of Environmental Estrogens and Suppression by FlavonoidsBioscience, Biotechnology, and Biochemistry, 2002
- Caspase-Dependent Cleavage of Cadherins and Catenins During Osteoblast ApoptosisJournal of Bone and Mineral Research, 2001
- Rutin Inhibits Ovariectomy-Induced Osteopenia in RatsJournal of Bone and Mineral Research, 2000
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.JCI Insight, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifenZeitschrift für Die Gesamte Experimentelle Medizin, 1997